Importance: Ischemic postconditioning of the heart during primary percutaneous coronary intervention (PCI) induced by repetitive interruptions of blood flow to the ischemic myocardial region immediately after reopening of the infarct-related artery may limit myocardial damage. Objective: To determine whether ischemic postconditioning can improve the clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI). Design, Setting, And Participants: In this multicenter, randomized clinical trial, patients with onset of symptoms within 12 hours, STEMI, and thrombolysis in myocardial infarction (TIMI) grade 0-1 flow in the infarct-related artery at arrival were randomized to conventional PCI or postconditioning. Inclusion began on March 21, 2011, through February 2, 2014, and follow-up was completed on February 2, 2016. Analysis was based on intention to treat. Interventions: Patients were randomly allocated 1:1 to conventional primary PCI, including stent implantation, or postconditioning performed as 4 repeated 30-second balloon occlusions followed by 30 seconds of reperfusion immediately after opening of the infarct-related artery and before stent implantation. Main Outcome and Measures: A combination of all-cause death and hospitalization for heart failure. Results: During the inclusion period, 1234 patients (975 men [79.0%] and 259 women [21.0%]; mean [SD] age, 62 [11] years) underwent randomization in the trial. Median follow-up was 38 months (interquartile range, 24-58 months). The primary outcome occurred in 69 patients (11.2%) who underwent conventional primary PCI and in 65 (10.5%) who underwent postconditioning (hazard ratio, 0.93; 95% CI, 0.66-1.30; P = .66). The hazard ratios were 0.75 (95% CI, 0.49-1.14; P = .18) for all-cause death and 0.99 (95% CI, 0.60-1.64; P = .96) for heart failure. Conclusions and Relevance: Routine ischemic postconditioning during primary PCI failed to reduce the composite outcome of death from any cause and hospitalization for heart failure in patients with STEMI and TIMI grade 0-1 flow at arrival. Trial Registration: clinicaltrials.gov Identifier: NCT01435408.
RCT Entities:
Importance: Ischemic postconditioning of the heart during primary percutaneous coronary intervention (PCI) induced by repetitive interruptions of blood flow to the ischemic myocardial region immediately after reopening of the infarct-related artery may limit myocardial damage. Objective: To determine whether ischemic postconditioning can improve the clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI). Design, Setting, And Participants: In this multicenter, randomized clinical trial, patients with onset of symptoms within 12 hours, STEMI, and thrombolysis in myocardial infarction (TIMI) grade 0-1 flow in the infarct-related artery at arrival were randomized to conventional PCI or postconditioning. Inclusion began on March 21, 2011, through February 2, 2014, and follow-up was completed on February 2, 2016. Analysis was based on intention to treat. Interventions: Patients were randomly allocated 1:1 to conventional primary PCI, including stent implantation, or postconditioning performed as 4 repeated 30-second balloon occlusions followed by 30 seconds of reperfusion immediately after opening of the infarct-related artery and before stent implantation. Main Outcome and Measures: A combination of all-cause death and hospitalization for heart failure. Results: During the inclusion period, 1234 patients (975 men [79.0%] and 259 women [21.0%]; mean [SD] age, 62 [11] years) underwent randomization in the trial. Median follow-up was 38 months (interquartile range, 24-58 months). The primary outcome occurred in 69 patients (11.2%) who underwent conventional primary PCI and in 65 (10.5%) who underwent postconditioning (hazard ratio, 0.93; 95% CI, 0.66-1.30; P = .66). The hazard ratios were 0.75 (95% CI, 0.49-1.14; P = .18) for all-cause death and 0.99 (95% CI, 0.60-1.64; P = .96) for heart failure. Conclusions and Relevance: Routine ischemic postconditioning during primary PCI failed to reduce the composite outcome of death from any cause and hospitalization for heart failure in patients with STEMI and TIMI grade 0-1 flow at arrival. Trial Registration: clinicaltrials.gov Identifier: NCT01435408.
Authors: Jacob Lønborg; Henning Kelbaek; Niels Vejlstrup; Erik Jørgensen; Steffen Helqvist; Kari Saunamäki; Peter Clemmensen; Lene Holmvang; Marek Treiman; Jan S Jensen; Thomas Engstrøm Journal: Circ Cardiovasc Interv Date: 2010-01-26 Impact factor: 6.546
Authors: Olivier C Manintveld; Maaike Te Lintel Hekkert; Ewout Jan van den Bos; Grietje M Suurenbroek; Dick H Dekkers; Pieter D Verdouw; Jos M Lamers; Dirk J Duncker Journal: Am J Physiol Heart Circ Physiol Date: 2006-11-22 Impact factor: 4.733
Authors: Henning Kelbæk; Dan Eik Høfsten; Lars Køber; Steffen Helqvist; Lene Kløvgaard; Lene Holmvang; Erik Jørgensen; Frants Pedersen; Kari Saunamäki; Ole De Backer; Lia E Bang; Klaus F Kofoed; Jacob Lønborg; Kiril Ahtarovski; Niels Vejlstrup; Hans E Bøtker; Christian J Terkelsen; Evald H Christiansen; Jan Ravkilde; Hans-Henrik Tilsted; Anton B Villadsen; Jens Aarøe; Svend E Jensen; Bent Raungaard; Lisette O Jensen; Peter Clemmensen; Peer Grande; Jan K Madsen; Christian Torp-Pedersen; Thomas Engstrøm Journal: Lancet Date: 2016-04-03 Impact factor: 79.321
Authors: Michel Ovize; Gary F Baxter; Fabio Di Lisa; Péter Ferdinandy; David Garcia-Dorado; Derek J Hausenloy; Gerd Heusch; Jakob Vinten-Johansen; Derek M Yellon; Rainer Schulz Journal: Cardiovasc Res Date: 2010-05-06 Impact factor: 10.787
Authors: Hans Erik Bøtker; Rajesh Kharbanda; Michael R Schmidt; Morten Bøttcher; Anne K Kaltoft; Christian J Terkelsen; Kim Munk; Niels H Andersen; Troels M Hansen; Sven Trautner; Jens Flensted Lassen; Evald Høj Christiansen; Lars R Krusell; Steen D Kristensen; Leif Thuesen; Søren S Nielsen; Michael Rehling; Henrik Toft Sørensen; Andrew N Redington; Torsten T Nielsen Journal: Lancet Date: 2010-02-27 Impact factor: 79.321
Authors: Derek J Hausenloy; Rajesh Kharbanda; Michael Rahbek Schmidt; Ulla Kristine Møller; Jan Ravkilde; Lisette Okkels Jensen; Thomas Engstrøm; Jose Manuel Garcia Ruiz; Nebosja Radovanovic; Erica F Christensen; Henrik Toft Sørensen; Manish Ramlall; Heerajnarain Bulluck; Richard Evans; Jennifer Nicholas; Rosemary Knight; Tim Clayton; Derek M Yellon; Hans Erik Bøtker Journal: Eur Heart J Date: 2015-08-01 Impact factor: 29.983
Authors: Regina Ye; Hani Jneid; Mahboob Alam; Barry F Uretsky; Dan Atar; Masafumi Kitakaze; Sean M Davidson; Derek M Yellon; Yochai Birnbaum Journal: Cardiovasc Drugs Ther Date: 2022-02-16 Impact factor: 3.727
Authors: Murat Sezer; Javier Escaned; Christopher J Broyd; Berrin Umman; Zehra Bugra; Ilke Ozcan; Mehmet Rasih Sonsoz; Alp Ozcan; Adem Atici; Emre Aslanger; Z Irem Sezer; Justin E Davies; Niels van Royen; Sabahattin Umman Journal: J Am Heart Assoc Date: 2022-05-16 Impact factor: 6.106
Authors: Jonathon P Audia; Xi-Ming Yang; Edward S Crockett; Nicole Housley; Ehtesham Ul Haq; Kristen O'Donnell; Michael V Cohen; James M Downey; Diego F Alvarez Journal: Basic Res Cardiol Date: 2018-07-10 Impact factor: 17.165